Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

Springer Science and Business Media LLC - Tập 16 - Trang 1-12 - 2024
Alberto Benussi1,2, Enrico Premi3, Mario Grassi4, Antonella Alberici2, Valentina Cantoni5, Stefano Gazzina6, Silvana Archetti7, Roberto Gasparotti8, Giorgio G. Fumagalli9, Arabella Bouzigues10, Lucy L. Russell10, Kiran Samra10, David M. Cash10, Martina Bocchetta10, Emily G. Todd10, Rhian S. Convery10, Imogen Swift10,11, Aitana Sogorb-Esteve10,11, Carolin Heller10,11, John C. van Swieten12, Lize C. Jiskoot12, Harro Seelaar12, Raquel Sanchez-Valle13, Fermin Moreno14,15, Robert Jr. Laforce16, Caroline Graff17,18, Matthis Synofzik19,20, Daniela Galimberti21,22, James B. Rowe23, Mario Masellis24, Maria Carmela Tartaglia25, Elizabeth Finger26, Rik Vandenberghe27,28,29, Alexandre Mendonça30, Pietro Tiraboschi31, Chris R. Butler32,33, Isabel Santana34,35, Alexander Gerhard36,37,38, Isabelle Le Ber39,40,41, Florence Pasquier42,43,44, Simon Ducharme45,46, Johannes Levin47,48,49, Sandro Sorbi50,51, Markus Otto52, Alessandro Padovani1,2, Jonathan D. Rohrer10,11, Barbara Borroni1,2
1Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
2Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili di Brescia, Brescia, Italy
3Vascular Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili di Brescia, Brescia, Italy
4Department of Brain and Behavioral Science, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy
5Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
6Department of Neurological and Vision Sciences, Neurophysiology Unit, ASST Spedali Civili di Brescia, Brescia, Italy
7Biotechnology Laboratory, Department of Diagnostics, ASST Spedali Civili di Brescia, Brescia, Italy
8Department of Medical and Surgical Specialties, Neuroradiology Unit, University of Brescia, Brescia, Italy
9Center for Mind/Brain Sciences-CIMeC, University of Trento, Rovereto, Italy
10Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK
11UK Dementia Research Institute at UCL, London, UK
12Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands
13Alzheimer’s Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Institut d’Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain
14Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Spain
15Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Spain
16Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Facultéde Médecine, Université Laval, Quebec City, Canada
17Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden
18Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden
19Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tubingen, Tubingen, Germany
20Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
21Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy
22Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
23Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust and Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
24Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada
25Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada
26Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada
27Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium
28Neurology Service, University Hospitals Leuven, Leuven, Belgium
29Leuven Brain Institute, KU Leuven, Leuven, Belgium
30Faculty of Medicine, University of Lisbon, Lisbon, Portugal
31Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
32Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK
33Department of Brain Sciences, Imperial College London, London, UK
34Neurology Service, Faculty of Medicine, University Hospital of Coimbra (HUC), University of Coimbra, Coimbra, Portugal
35Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
36Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK
37Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg-Essen, Essen, Germany
38Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK
39Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France
40Centre de Référence Des Démences Rares Ou Précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France
41Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France
42Univ Lille, Lille, France
43Lille – France
44CHU, CNR-MAJ, Labex Distalz, LiCEND Lille, Lille, France
45Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, Canada
46McConnell Brain Imaging Centre, Montreal Neurological Institute, Department of Neurology & Neurosurgery, McGill University, Montreal, Canada
47Neurologische Klinik Und Poliklinik, Ludwig-Maximilians-Universität, Munich, Germany
48Center for Neurodegenerative Diseases (DZNE), Munich, Germany
49Munich Cluster of Systems Neurology, Munich, Germany
50Department of NEUROFARBA, University of Florence, Florence, Italy
51IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy
52Department of Neurology, University of Ulm, Ulm, Germany

Tóm tắt

The Genetic Frontotemporal Initiative Staging Group has proposed clinical criteria for the diagnosis of prodromal frontotemporal dementia (FTD), termed mild cognitive and/or behavioral and/or motor impairment (MCBMI). The objective of the study was to validate the proposed research criteria for MCBMI-FTD in a cohort of genetically confirmed FTD cases against healthy controls. A total of 398 participants were enrolled, 117 of whom were carriers of an FTD pathogenic variant with mild clinical symptoms, while 281 were non-carrier family members (healthy controls (HC)). A subgroup of patients underwent blood neurofilament light (NfL) levels and anterior cingulate atrophy assessment. The core clinical criteria correctly classified MCBMI vs HC with an AUC of 0.79 (p < 0.001), while the addition of either blood NfL or anterior cingulate atrophy significantly increased the AUC to 0.84 and 0.82, respectively (p < 0.001). The addition of both markers further increased the AUC to 0.90 (p < 0.001). The proposed MCBMI criteria showed very good classification accuracy for identifying the prodromal stage of FTD.

Tài liệu tham khảo

Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14. Kertesz A, McMonagle P, Blair M, et al. The evolution and pathology of frontotemporal dementia. Brain. 2005;128:1996–2005. Carneiro F, Saracino D, Huin V, et al. Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations. Parkinsonism Relat Disord. 2020;80:73–81. Gasca-Salas C, Masellis M, Khoo E, et al. Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: a systematic review and meta-analysis. PLoS One. 2016;11:1–20. Benussi A, Alberici A, Samra K, et al. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia. Alzheimer’s Dement. 2022;18:1408–23. van der Ende EL, Meeter LH, Poos JM, et al. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. Lancet Neurol. 2019;18:1103–11. McCarthy J, Borroni B, Sanchez-Valle R, et al. Data-driven staging of genetic frontotemporal dementia using multi-modal MRI. Hum Brain Mapp. 2022;43:1821–35. Borroni B, Padovani A. Dementia: a new algorithm for molecular diagnostics in FTLD. Nat Rev Neurol. 2013;9:241–2. Greaves CV, Rohrer JD. An update on genetic frontotemporal dementia. J Neurol. 2019;266:2075–86. Rohrer JD, Nicholas JM, Cash DM, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253–62. Moore KM, Nicholas J, Grossman M, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 2020;19:145–56. Staffaroni AM, Quintana M, Wendelberger B, et al. Temporal order of clinical and biomarker changes in familial frontotemporal dementia. Nat Med. 2022;28:2194–206. Poos JM, Moore KM, Nicholas J, et al. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog. Alzheimers Res Ther. 2022;14:1–12. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–72. Knopman DS, Kramer JH, Boeve BF, et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain. 2008;131:2957–68. Miyagawa T, Brushaber D, Syrjanen J, et al. Utility of the global CDR ® plus NACC FTLD rating and development of scoring rules: data from the ARTFL/LEFFTDS Consortium. Alzheimer’s Dement. 2020;16:106–17. Corrigan JD, Hinkeldey NS. Relationships between parts A and B of the Trail Making Test. J Clin Psychol. 1987;43:402–9. Lezak MD, Howieson D, Bigler E, et al. Neuropsychological assessment. (5th ed.). Oxford University Press; 2012. Bertoux M, Delavest M, De Souza LC, et al. Social cognition and emotional assessment differentiates frontotemporal dementia from depression. J Neurol Neurosurg Psychiatry. 2012;83:411–6. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers. Alzheimer Dis Assoc Disord. 2006;20:210–6. Moore K, Convery R, Bocchetta M, et al. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort. Applied Neuropsychology Adult. 2020;29:1–8. Samra K, MacDougall AM, Peakman G, et al. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales. J Neurol. 2023;270:1466–77. Kuhle J, Barro C, Andreasson U, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016;54:1655–61. Harper L, Fumagalli GG, Barkhof F, et al. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain. 2016;139:1211–25. Chu M, Liu L, Wang J, et al. Investigating the roles of anterior cingulate in behavioral variant frontotemporal dementia: a PET/MRI study. J Alzheimer’s Dis. 2021;84:1771–9. Barker MS, Manoochehri M, Rizer SJ, et al. Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia. Cortex. 2021;139:99–115. Staffaroni AM, Bajorek L, Casaletto KB, et al. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimer’s Dement. 2020;16:11–21. Malpetti M, Jones PS, Tsvetanov KA, et al. Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes. Alzheimer’s Dement. 2020;17:969–83. Tavares TP, Mitchell DGV, Coleman KKL, et al. Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry. 2020;91:975–84. Benussi A, Premi E, Gazzina S, et al. Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia. JAMA Netw Open. 2021;4:1–17. Ducharme S, Dols A, Laforce R, et al. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain. 2020;143:1632–50. Jack CR, Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14:535–62. McKeith IG, Ferman TJ, Thomas AJ, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94:743–55. Benussi A, Ashton NJ, Karikari TK, et al. Prodromal frontotemporal dementia: clinical features and predictors of progression. Alzheimers Res Ther. 2021;13:188. Benussi A, Cantoni V, Rivolta J, et al. Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration. Alzheimers Res Ther. 2022;14:155. Gami-Patel P, Scarioni M, Bouwman FH, et al. The severity of behavioural symptoms in FTD is linked to the loss of GABRQ-expressing VENs and pyramidal neurons. Neuropathol Appl Neurobiol. 2022;48. https://doi.org/10.1111/nan.12798. Rus T, Perovnik M, Vo A, et al. Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia. Hum Brain Mapp. Published Online First: 5 November 2022. https://doi.org/10.1002/hbm.26140. Heuer HW, Wang P, Rascovsky K, et al. Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Alzheimer’s Dement. 2020;16:60–70. Capozzo R, Sassi C, Hammer MB, et al. Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy. Alzheimer’s Dement. 2017;13:858–69. Benussi A, Libri I, Premi E, et al. Differences and similarities between familial and sporadic frontotemporal dementia: an Italian single‐center cohort study. Alzheimer’s Dement. 2022;8. https://doi.org/10.1002/trc2.12326. Mori K, Arzberger T, Grässer FA, et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126:881–93. Zu T, Gibbens B, Doty NS, et al. Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci U S A. 2011;108:260–5. Bieniek KF, Murray ME, Rutherford NJ, et al. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion. Acta Neuropathol. 2013;125:289–302. Ward ME, Chen R, Huang H-Y, et al. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. https://www.science.org. Giannini LAA, Ohm DT, Rozemuller AJM, et al. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration. Acta Neuropathol. 2022;144:1065–84. Paternicò D, Premi E, Gazzina S, et al. White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations. Neurobiol Aging. 2016;38:176–80. Sudre CH, Bocchetta M, Cash D, et al. White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort. Neuroimage Clin. 2017;15:171–80. Swift IJ, Sogorb-Esteve A, Heller C, et al. Fluid biomarkers in frontotemporal dementia: past, present and future. J Neurol Neurosurg Psychiatry. 2020;92:204–15 Barker MS, Gottesman RT, Manoochehri M, et al. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain. 2022;145:1079–97.
Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 16

1-12

Thông tin tác giả